Status:
UNKNOWN
Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD
Lead Sponsor:
Federico II University
Conditions:
Peripheral Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
The objective of the present study was to evaluate the prognostic impact of prolonged dual antiplatelet therapy (DAPT) with acetylsalicylic acid plus clopidogrel on the incidence of major adverse card...
Eligibility Criteria
Inclusion
- LE-PAD at stage 2 of Fontaine's classification (intermittent claudication)
- successful PTA of aorto-iliac, femoro-popliteal ore below-the-knee segments
Exclusion
- critical limb ischemia
- recent acute coronary syndrome (\< 12 months)
- recent cerebrovascular event (\< 12 months)
- recent myocardial, carotid or peripheral revascularization (\< 12 months)
- recent history of bleeding (\< 12 months)
- other indication for clopidogrel therapy
- indication for anticoagulation
- de-compensated heart failure
- malignant neoplasm
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02798913
Start Date
January 1 2016
End Date
July 1 2020
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Advanced Biomedical Sciences, University of Naples "Federico II"
Naples, Italy, 80131